Related Experiment Videos
Total synthesis of (+)-thiazinotrienomycin E.
1Department of Chemistry, Monell Chemical Senses Center, University of Pennsylvania, Philadelphia 19104, USA. smithab@sas.upenn.edu
Organic Letters
|May 29, 2000
Summary
The first total synthesis of the novel cytotoxic antibiotic (+)-thiazinotrienomycin E was achieved. This research advances ansamycin antibiotic synthesis and drug discovery efforts.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Chemical Biology
Background:
- Ansamycin antibiotics are a class of natural products with significant cytotoxic activity.
- Thiazinotrienomycin E represents a novel subclass of ansamycin antibiotics.
- The development of efficient synthetic routes is crucial for exploring the therapeutic potential of novel antibiotics.
Purpose of the Study:
- To achieve the first total synthesis of (+)-thiazinotrienomycin E.
- To develop and apply novel synthetic methodologies for constructing complex ansamycin macrolides.
- To provide a scalable route for potential pharmaceutical development.
Main Methods:
- Stereoselective construction of the aromatic fragment utilizing TBS-protected aniline.
- Improved synthesis of key intermediate (-)-19.
- Application of the Kocienski modified Julia olefination for E,E,E-triene subunit assembly.
- Mukaiyama macrolactamization for the formation of the thiazinotrienomycin macrolide.
Main Results:
- Successful completion of the first total synthesis of (+)-thiazinotrienomycin E.
- Efficient construction of the aromatic core and elaboration of the triene side chain.
- Demonstration of a robust strategy for ansamycin macrolide synthesis.
Conclusions:
- The developed synthetic route provides access to (+)-thiazinotrienomycin E, a novel cytotoxic ansamycin.
- This synthesis validates new methodologies applicable to complex natural product synthesis.
- The findings open avenues for further investigation into the biological activity and therapeutic applications of thiazinotrienomycins.